Scilex Holding (SCLXW) Cash from Operations (QoQ) (2020 - 2026)

Scilex Holding (SCLXW) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 106.30%
Dec 31, 2025 -313.40%
Sep 30, 2025 15.42%
Jun 30, 2025 18.08%
Mar 31, 2025 137.06%
Dec 31, 2024 -50.44%
Sep 30, 2024 121.25%
Jun 30, 2024 -75.39%
Mar 31, 2024 274.23%
Dec 31, 2023 -191.36%
Sep 30, 2023 143.79%
Jun 30, 2023 -73.98%
Mar 31, 2023 -968.14%
Dec 31, 2022 -128.62%
Sep 30, 2022 120.54%
Jun 30, 2022 -14.95%
Mar 31, 2022 61.63%
Dec 31, 2021 -19,600.37%
Sep 30, 2021 74.26%
Jun 30, 2021 -11.59%